AFT Pharmaceuticals : Annual Report - FY2023

For personal use only

2023 ANNUAL REPORT

For personal use only

For personal use only

Developing innovative products that

make a real difference to your health.

For personal use only

Contents

At a Glance	4
Chairman and CEO's Report	6
Business Focus:
- Regional Performance	10
- Research and Development	16
Sustainability	20
Reconciliation of EBITDA to GAAP	35
Directors	36
Management Team	38
Independent Auditor's Report	41
Financial Statements	44
Statutory Disclosures	74
Directory	83

This report provides a summary review of AFT's operational and financial performance for the year to 31 March 2023 and should be read in conjunction with the company's financial statements on pages 44 to 73 of this report.

The information provided in this report has been compiled in accordance with relevant law, rules and corporate governance recommendations for investor reporting. Financial information has been prepared in accordance with appropriate accounting standards and has been audited by Deloitte Limited.

Throughout this report we have focused on what we believe matters most to our stakeholders and our business. We have endeavoured to ensure all information is accurate through internal verification and other approval processes.

2 WORKING TO IMPROVE YOUR HEALTH

For personal use only

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories around the world.

A F T P H A R M A C E U T I C A L S ANNUAL REPORT 2023

3